A carregar...
Access to innovative cancer medicines in a middle-income country - the case of Mexico
BACKGROUND: Cancer has become the third cause of death in Mexico. Treatment for cancer is often complex and lengthy. New and better medicines enter the market at high prices, which may limit access. Like most Latin American countries, Mexico has an essential cancer medicines list that includes innov...
Na minha lista:
| Publicado no: | J Pharm Policy Pract |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6199792/ https://ncbi.nlm.nih.gov/pubmed/30386627 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40545-018-0153-y |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|